High‐level production of alternatively spliced soluble interleukin‐6 receptor in serum of patients with adult T‐cell leukaemia/HTLV‐I‐associated myelopathy
- 1 November 1998
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 95 (3) , 360-369
- https://doi.org/10.1046/j.1365-2567.1998.00622.x
Abstract
We have previously shown, using human T‐cell lymphocytotrophic virus‐I (HTLV‐I)‐infected cell lines, that soluble interleukin‐6 receptor (sIL‐6R) is generated through an alternative splicing mechanism. In this study, we examined human sera for the presence of alternatively spliced soluble IL‐6R (AS‐sIL‐6R). We produced a monoclonal antibody (mAb) recognizing the unique sequence of AS‐sIL‐6R peptide, generated by an altered reading frame. We also made recombinant AS‐sIL‐6R protein in Spodoptera frugiperda‐9 (Sf‐9) cells carrying baculovirus, which encoded altered sIL‐6R or conventional IL‐6R cDNA. mAbs specifically recognized AS‐sIL‐6R, but not conventional IL‐6R, as demonstrated by Western blot analyses, fluorescence‐activated cell sorter, immunofluorescence analyses and enzyme‐linked immunosorbent assay (ELISA). We adapted an ELISA system and used it for detection of altered sIL‐6R in sera from 23 healthy persons, 12 patients with adult T‐cell leukaemia (ATL) and 13 patients with HTLV‐I‐associated myelopathy (HAM). Serum levels of AS‐sIL‐6R were 6·4 or 6·1 times greater in ATL (28·7±20·4 ng/ml, PP<0·0001) than in healthy individuals (4·5±2·1 ng/ml). High levels of AS‐sIL‐6R were also observed in plasma from rheumatoid arthritis patients and in persons with elevated levels of alanine aminotransferase (ALT), antinuclear antibody (ANA), or α‐fetoprotein (AFP). However, in human immunodeficiency virus‐1 (HIV‐1), hepatitis B virus (HBV) or hepatitis C virus (HCV)‐infected individuals, AS‐sIL‐6R levels were not elevated. In this study, we confirmed that AS‐sIL‐6R is indeed present in human sera. These observations suggest that alternative splicing of IL‐6R mRNA is of consequence in ATL, HAM and in some autoimmune diseases. The HTLV‐I‐infected T cells appeared to play an important role in AS‐sIL‐6R production.Keywords
This publication has 28 references indexed in Scilit:
- Altered interleukin‐2 receptor α‐chain is expressed in human T‐cell leukaemia virus type‐I‐infected T‐cell lines and human peripheral blood mononuclear cells of adult T‐cell leukaemia patients through an alternative splicing mechanismImmunology, 1997
- The soluble form of the IL-6 receptor (sIL-6Rα) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6Rα-induced AIDS-KS cell growthInternational Immunology, 1996
- Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.The Journal of Experimental Medicine, 1995
- Clinical significance of elevated soluble interleukin‐6 receptor levels in the sera of patients with plasma cell dyscrasiasBritish Journal of Haematology, 1995
- INTERLEUKIN-6 (IL-6) INDUCES THE PROLIFERATION OF SYNOVIAL FIBROBLASTIC CELLS IN THE PRESENCE OF SOLUBLE IL-6 RECEPTORRheumatology, 1995
- Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in paget's diseaseJournal of Bone and Mineral Research, 1994
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) ReceptorScience, 1988
- Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggeringCell, 1987